NCT02634931 2019-02-20Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis ComplexNobelpharmaPhase 3 Completed94 enrolled
NCT01241591 2018-12-26A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque PsoriasisPfizerPhase 3 Completed1,101 enrolled 46 charts
NCT02635789 2017-02-02Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)NobelpharmaPhase 3 Completed62 enrolled